rethinkMushrooms Search
Menu
Research citation

The mushroom Agaricus Blazei Murill in combination with metformin and gliclazide improves insulin resistance in type 2 diabetes: a randomized, double-blinded, and placebo-controlled clinical trial.

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

The mushroom Agaricus Blazei Murill in combination with metformin and gliclazide improves insulin resistance in type 2 diabetes: a randomized, double-blinded, and placebo-controlled clinical trial.

Journal of alternative and complementary medicine (New York, N.Y.), 13(1), 97-102

Citation

Hsu, Chung-Hua; Liao, Yang-Li; Lin, Su-Ching; Hwang, Kung-Chang; Chou, Pesus. (2007). The mushroom Agaricus Blazei Murill in combination with metformin and gliclazide improves insulin resistance in type 2 diabetes: a randomized, double-blinded, and placebo-controlled clinical trial.. Journal of alternative and complementary medicine (New York, N.Y.), 13(1), 97-102.